Phase 1/2a Clinical Trial to Evaluate Safety and Preliminary Efficacy of CRG-150 in Metastatic Triple-Negative Breast Cancer, HR+ HER2− Breast Cancer, and Prostate Cancer at Leading Academic Medical C ...
The first Enhanced Games, where PED use was encouraged, ended with only one world record beaten. But the athletes collected ...
Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...
Philadelphia is enduring one of its warmest 4th of July celebrations on record, with temperatures exceeding 100 degrees ...
“This has been by far the hardest thing I've ever had to quit.” ...
Houston biopharma company CoRegen said it has received US Food and Drug Administration clearance to begin a Phase I/II trial of CRG-150, an adoptive cell therapy targeting steroid receptor coactivator ...
Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. From your friendly ...
It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local ...
Medicare has expanded access to GLP-1 weight-loss medications. These drugs may also help treat addiction. Primary care ...
Years ago, LSD was seen as the evil stepchild of drugs. Today, research indicates LSD may treat anxiety and depression, and ...
The strain of the virus that's responsible for the current outbreak has no specific treatments or preventive measures. Three ...
GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results